Company logo

APM - Aptorum Group Limited

NASDAQ -> Healthcare -> Biotechnology
London, United Kingdom
Type: Equity

APM price evolution
APM
(in millions $) 30 Jul 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Current assets
Cash $0.34 $1.88 $1.88 $4.07
Short term investments $0.1 $0.1 $0.15
Net receivables $0.71 $1.39 $1.39 $1.94
Inventory $0.03 $0.03 $0.03
Total current assets $1.9 $7.07 $7.07 $9.32
Long term investments $9.74 $9.74 $9.74
Property, plant & equipment $2.5 $3.17 $3.17 $3.83
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $14.41 $20.87 $20.87 $24.02
Current liabilities
Accounts payable $0.48 $0.12 $0.12 $4.84
Deferred revenue
Short long term debt $6.32 $6.32 $3.36
Total current liabilities $1.43 $12.5 $12.5 $8.21
Long term debt $0.5 $0.5
Total noncurrent liabilities
Total debt
Total liabilities -$7.43 $13.03 $13.03 $8.37
Shareholders' equity
Retained earnings -$70.82 -$65.34 -$65.34 -$57.42
Other shareholder equity $0.03 -$7.84 -$7.84 -$6.97
Total shareholder equity $7.83 $7.83 $15.65
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $1.88 $8.13 $3.5 $5.19
Short term investments $0.1 $0.24 $28.39 $1.06
Net receivables $1.39 $3.63 $0.34 $0.49
Inventory $0.03 $0.04 $0.04 $0.03
Total current assets $7.07 $12.69 $33.66 $8.03
Long term investments $9.74 $4.16 $4.08 $7.11
Property, plant & equipment $3.17 $3.89 $5.23 $7.09
Goodwill & intangible assets
Total noncurrent assets $10.57 $15.92
Total investments
Total assets $20.87 $21.91 $44.23 $23.95
Current liabilities
Accounts payable $0.12 $0.69 $0.94 $0.73
Deferred revenue
Short long term debt $6.32 $0.06 $0.2 $0.09
Total current liabilities $12.5 $4.38 $3.87 $2.67
Long term debt $0.5 $2.06 $6.43
Total noncurrent liabilities $2.21 $6.43
Total debt
Total liabilities $13.03 -$1.7 $2.4 $7.59
Shareholders' equity
Retained earnings -$65.34 -$55.54 -$30.49 -$37.56
Other shareholder equity -$7.84 -$0 $0.05 -$0.01
Total shareholder equity $7.83 $23.61 $41.83 $16.36
(in millions $) 30 Jul 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Revenue
Total revenue $0.43 $0.38 $0.38 $0.26
Cost of revenue $0.34 $0.34 $0.27
Gross Profit $0.01 $0.04 $0.04 -$0
Operating activities
Research & development $2.36 $2.36 $2.25
Selling, general & administrative $2.18 $2.18 $1.88
Total operating expenses $5.82 $4.91 $4.91 $4.49
Operating income -$4.53 -$4.53 -$4.23
Income from continuing operations
EBIT
Income tax expense
Interest expense -$0.1 -$0 -$0
Net income
Net income -$5.49 -$3.96 -$3.96 -$0.94
Income (for common shares) -$3.96 -$3.96 -$0.94
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $1.3 $1.54 $0.91 $0.54
Cost of revenue $1.22 $1.46 $1.02 $0.79
Gross Profit $0.08 $0.08 -$0.1 -$0.26
Operating activities
Research & development $9.22 $9.91 $10.4 $6.94
Selling, general & administrative $8.11 $7.8 $7.36 $10.78
Total operating expenses $18.81 $20.75 $21.19 $17.54
Operating income -$17.51 -$19.21 -$20.28 -$17
Income from continuing operations
EBIT
Income tax expense
Interest expense $0.24 $3.7
Net income
Net income -$9.8 -$25.05 $7.07 -$18.69
Income (for common shares) -$9.8 -$25.05 $6.31 -$18.69
(in millions $) 30 Jul 2023 31 Dec 2022 30 Sep 2022 30 Jul 2022
Net income -$3.96 -$3.96
Operating activities
Depreciation $0.26 $0.26
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$2.7 -$2.7
Investing activities
Capital expenditures -$0.02 -$0.02
Investments
Total cash flows from investing $0.56 -$0.13 -$0.13 $2.71
Financing activities
Dividends paid
Sale and purchase of stock $0.01 $0.01
Net borrowings $1.74 $1.74
Total cash flows from financing $1.09 $1.74 $1.74 $3.14
Effect of exchange rate
Change in cash and equivalents -$4.54 -$1.09 -$1.09 -$1.07
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$9.8 -$27.11 $4.92 -$20.12
Operating activities
Depreciation $1.09 $1.19 $1.33 $1.3
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$12.32 -$14.65 -$15.93 -$13.38
Investing activities
Capital expenditures -$0.19 -$0.14 -$0.16 -$1.11
Investments
Total cash flows from investing $2.44 $16.51 $1.84 -$0.11
Financing activities
Dividends paid
Sale and purchase of stock $0.17 $4.82 $17.5
Net borrowings $6.45 -$2.04 -$4.36 -$13.65
Total cash flows from financing $6.63 $2.78 $12.42 -$7.32
Effect of exchange rate
Change in cash and equivalents -$3.25 $4.64 -$1.67 -$20.81
Fundamentals
Market cap $49.17M
Enterprise value N/A
Shares outstanding 5.18M
Revenue $1.46M
EBITDA N/A
EBIT N/A
Net Income -$14.35M
Revenue Q/Q 63.40%
Revenue Y/Y N/A
P/E ratio -3.43
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 33.60
P/B ratio N/A
Book/Share N/A
Cash/Share 0.07
EPS -$2.77
ROA -71.60%
ROE N/A
Debt/Equity 1.66
Net debt/EBITDA N/A
Current ratio 1.32
Quick ratio N/A